Synendos Therapeutics is based in Basel, Switzerland. It has raised $31M in total funding. Latest round: Series A.
Synendos Therapeutics is based in Basel, Switzerland. Synendos Therapeutics has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2020. The round record for Synendos Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Kurma Partners, Sunstone Life Science Ventures, BERNINA BioInvest, Schroder Adveq, High-Tech Gründerfonds, Lichtsteiner Foundation and 3 others. 9 distinct backers are named across the disclosed rounds.
Synendos Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Basel below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026